| 2022 |
Chen Chiang-Yun, Lin Yu-Wei, Wang Szu-Wen, Lin Yung-Chu, Cheng Yang-Yu, (Ren Chien-Tai, Wong Chi-Huey, Wu Chung-Yi*, Synthesis of Azido-Globo H Analogs for Immunogenicity Evaluation, ACS Central Science, vol. 8(1), 77-85, 2022 |
| 2022 |
Lin Tzu-Lung, Yang Feng-Ling, (Ren Chien-Tai, Pan Yi-Jiun, Liao Kuo-Shiang, Tu I-Fan, Chang Yu-Pei, Cheng Yang-Yu, Wu Chung-Yi*, Wu Shih-Hsiung*, Wang Jin-Town*, Development of Klebsiella pneumoniae Capsule Polysaccharide-Conjugated Vaccine Candidates Using Phage Depolymerases, Frontiers in Immunology, vol. 13, 843183, 1-13, 2022 |
| 2022 |
Wu NL, Huang DY, (Hsieh SL, Dai YS, Lin WW, Decoy receptor 3 is involved in epidermal keratinocyte commitment to terminal differentiation via EGFR and PKC activation., Experimental & molecular medicine, vol. 54(4), 542-551, 2022 |
| 2022 |
Wu YH, Mo ST, Chen IT, Hsieh FY, (Hsieh SL, Zhang J, Lai MZ, Caspase-8 inactivation drives autophagy-dependent inflammasome activation in myeloid cells., Science advances, vol. 8(45), eabn9912, 2022 |
| 2022 |
Hsu YW, Huang H CH, Huang WC, Yeh YH, Hsiao CD, Chang WC**, (Hsieh SL)**, Human rs75776403 Polymorphism Links Differential Phenotypic and Clinical Outcomes to a CLEC18A p.T151M-Driven Multiomics, JOURNAL OF BIOMEDICAL SCIENCE, vol. 29(1), 43, 2022 |
| 2022 |
Weng SC, Wen MC, (Hsieh SL, Chen NJ, Tarng DC*, Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling, FRONTIERS IN IMMUNOLOGY, vol. 13, 879648, 2022 |
| 2022 |
Sung PS, Yang SP, Perng YC, Sun CP, Tao MH, (Hsieh SL)*, CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation, JOURNAL OF BIOMEDICAL SCIENCE, vol. 29(1), 52, 2022 |
| 2022 |
Sung PS, Peng YC, Yang SP, Chiu CH, (Hsieh SL)*, CLEC5A is critical in Pseudomonas aeruginosa-induced NET formation and acute lung injury, JCI INSIGHT, vol. 7(18), e156613, 2022 |
| 2022 |
Lin EH, Hsu JW, Lee TF, Hsu CF, Lin TH, Jan YH, Chang HY, Cheng CM, Hsu HJ, Chen WW, Chen BH, Tsai HF, Li JJ, Huang CY, Chuang SH, Chang JM, (Hsiao M, Wu CW, Targeting cancer stemness mediated by BMI1 and MCL1 for non-small cell lung cancer treatment., JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, vol. 26(15), 4305-4321, 2022 |
| 2022 |
Li Chien-Hsiu, Chan Ming-Hsien, Liang Shu-Mei, Chang Yu-Chan, (Hsiao Michael, Fascin-1: Updated biological functions and therapeutic implications in cancer biology, BBA Advances, vol. 2, 100052, 2022 |
| 2022 |
Tsai MT, Sun YS, Keerthi M, Panda AK, Dhawan U, Chang YH, Lai CF, (Hsiao M, Wang HY, Chung RJ, Oral Cancer Theranostic Application of FeAu Bimetallic Nanoparticles Conjugated with MMP-1 Antibody, NANOMATERIALS, vol. 12(1), 61, 2022 |
| 2022 |
Chang ZX, Li CH, Chang YC, Huang CYF, Chan MH, (Hsiao M)*, Novel Monodisperse FePt Nanocomposites for T2-weighted Magnetic Resonance Imaging: Biomedical Theranostics Applications [COVER STORY], NANOSCALE ADVANCES, vol. Jan 21;4(2), 377-386, 2022 |
| 2022 |
Chou CC, Hua KT, Chen MW, Wu CJ, Hsu CH, Wang JT, (Hsiao M, Wei LH, Discovery and Characterization of A Monoclonal Antibody Targeting A Conformational Epitope of IL-6/IL-6Rα to Inhibit IL-6/ IL-6Rα/gp130 Hexameric Signaling Complex Formation, MABS, vol. 14(1), 2029675, 2022 |
| 2022 |
Chang YC, Chang PM, Li CH, Chan MH, Lee YJ, Chen MH, (Hsiao M)*, Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer., FRONTIERS IN ONCOLOGY, vol. Jan 21;11, 811635, 2022 |
| 2022 |
Chan MH, Huang WT, Satpathy A, Su TY, (Hsiao M)*, Liu RS, Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics, PHARMACEUTICS, vol. Feb 21;(14), 459, 2022 |
| 2022 |
Li LJ, Chang PM, Li CH, Lai TC, Chang YC, Su CY, Chen CL, Chang WM, (Hsiao M)*, Fung SW, FAS Receptor Regulates NOTCH Activity through ERK-JAG1 Axis Activation and Controls Oral Cancer Stemness Ability and Pulmonary Metastasis, CELL DEATH DISCOVERY, vol. In Press, 1, 2022 |
| 2022 |
Chuang HH, Zhen YY, Tsai YC, Chuang CH, (Hsiao M, Huang MS, Yang CJ, FAK in Cancer: From Mechanisms to Therapeutic Strategies, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. Feb 2;23(3), 1726, 2022 |
| 2022 |
Wen YC, Chen WY, Tram VTN, Yeh HL, Chen WH, Jiang KC, Abou-Kheir W, Huang J, (Hsiao M, Liu YN, Pyruvate Kinase L/R Links Metabolism Dysfunction to Neuroendocrine Differentiation of Prostate Cancer by ZBTB10 Deficiency, CELL DEATH & DISEASE, vol. 13(3), 252, 2022 |
| 2022 |
Wen YC, Liu CL, Yeh HL, Chen WH, Jiang KC, Tram VTN, (Hsiao M, Huang J, Chen WY, Liu YN, PCK1 Regulates Neuroendocrine Differentiation in A Positive Feedback Loop of LIF/ZBTB46 Signalling in Castration-resistant Prostate Cancer, BRITISH JOURNAL OF CANCER, vol. 126(5), 778-790, 2022 |
| 2022 |
Tung MC, Lin YW, Lee WeJ, Wen YC, Liu YC, Chen JQ, (Hsiao M, Yang YC, Chien MH, Targeting DRD2 by the Antipsychotic Drug, Penfluridol, Retards Growth of Renal Cell Carcinoma via Inducing Stemness Inhibition and Autophagy-mediated Apoptosis, CELL DEATH & DISEASE, vol. Apr23;13(4), 400, 2022 |
| 2022 |
Chang YC, Li C, Chan MH, Chen MH, Yeh CN, (Hsiao M)*, Regorafenib Inhibits Epithelial-mesenchymal Transition and Suppresses Cholangiocarcinoma Metastasis via YAP1-AREG Axis, CELL DEATH & DISEASE, vol. 13(4), 391, 2022 |
| 2022 |
Chan MH, Chang ZX, Huang CYF, Lee LJ, Liu RS, (Hsiao M)*, Integrated Therapy Platform of Exosomal System: Hybrid Inorganic/Organic Nanoparticles with Exosomes for Cancer Treatment [COVER STORY], NANOSCALE HORIZONS, vol. 7(4), 352-367, 2022 |
| 2022 |
Chan MH, Huang WT, Chen KC, Su TY, Chan YC, (Hsiao M)*, Liu RS, The Optical Research Progress of Nanophosphors Composed of Transition Elements in the Fourth Period of Near-infrared Windows I and II for Deep-tissue Theranostics [COVER STORY], NANOSCALE, vol. May21;14(19), 7123-7136, 2022 |
| 2022 |
Lin CC, Cheng PY, (Hsiao M, Liu YP, Effects of RU486 in Treatment of Traumatic Stress-Induced Glucocorticoid Dysregulation and Fear-Related Abnormalities: Early versus Late Intervention, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. May14;23(10), 5494, 2022 |
| 2022 |
Li CH, Chang YC, (Hsiao M)*, Chan MH, Ultrasound and Nanomedicine for Cancer-Targeted Drug Delivery: Screening, Cellular Mechanisms and Therapeutic Opportunities, PHARMACEUTICS, vol. June 16;14(6), 1282, 2022 |
| 2022 |
Lai TC, Lee YL, Lee WJ, Hung WY, Cheng GZ, Chen JQ, (Hsiao M, Chien MH, Chang JH, Synergistic Tumor Inhibition via Energy Elimination by Repurposing Penfluridol and 2-Deoxy-D-Glucose in Lung Cancer, CANCERS, vol. June 1;14(11), 2750, 2022 |
| 2022 |
Chou PC, Liu CM, Weng CH, Yang KC, Cheng ML, Lin YC, Yang RB, Shyu BC, Shyue SK, Liu JD, Chen SP, (Hsiao M, Hu YF, Fibroblasts Drive Metabolic Reprogramming in Pacemaker Cardiomyocytes [COVER STORY], CIRCULATION RESEARCH, vol. June24;131(1), 6-20, 2022 |
| 2022 |
Li LJ, Li CH, Chang PM, Lai TC, Yong CY, Feng SW, (Hsiao M, Chang WM, Huang CYF., Dehydroepiandrosterone (DHEA) Sensitizes Irinotecan to Suppress Head and Neck Cancer Stem-Like Cells by Downregulation of WNT Signaling, FRONTIERS IN ONCOLOGY, vol. Jul13;12, 775541, 2022 |
| 2022 |
Chuang HH, Huang MS, Zhen YY, Chuang CH, Lee YR, (Hsiao M)*, Yang CJ, FAK Executes Anti-Senescence via Regulating EZH2 Signaling in Non-Small Cell Lung Cancer Cells, BIOMEDICINES, vol. Aug 10;10(8), 1937, 2022 |
| 2022 |
Li CH, Chan MH, Chang YC, (Hsiao M)*, The CHST11 Gene Is Linked to Lung Cancer and Pulmonary Fibrosis, JOURNAL OF GENE MEDICINE, vol. e3451, 1, 2022 |
